All spots in the tumor showed lowest expression in TNMH, e.g., ATP5F1B fr (spot 1604), HSP8A (spot 1703), spot 2207, actb (spot 2802), spot 2806 and spot 3603, Table 2. Here, ATP5F1B is linked to neoplasm.